Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review

Joanna E. Fardell; Janine Vetsch; T. Trahair; M. K. Mateos; M. A. Grootenhuis; L. M. Touyz; G. M. Marshall; C. E. Wakefield

doi:10.1002/pbc.26489

Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review

Joanna E. Fardell, Janine Vetsch, T. Trahair, M. K. Mateos, M. A. Grootenhuis, L. M. Touyz, G. M. Marshall, C. E. Wakefield

Research output: Contribution to journal › Review article › peer-review

73 Citations (Scopus)

Abstract

Children with acute lymphoblastic leukemia (ALL) undergo intense anticancer treatment. We systematically reviewed 22 studies evaluating 2,073 ALL patients’ health-related quality of life (HRQL) and its clinical/demographic correlates during treatment. Overall HRQL was significantly reduced on treatment. Despite HRQL improvements over time, longitudinal studies reported a proportion of children continued to experience reduced HRQL after treatment completion. We found inconsistent associations between clinical/demographic factors and HRQL outcomes. Tentative evidence emerged for worse HRQL being associated with intensive phases of chemotherapy, corticosteroid therapy, experiencing greater toxicity, older age, and female sex. Longitudinal studies are needed to identify children at-risk of reduced HRQL.

Original language	English
Article number	e26489
Journal	Pediatric Blood and Cancer
Volume	64
Issue number	9
DOIs	https://doi.org/10.1002/pbc.26489
Publication status	Published - Sept 2017
Externally published	Yes

Keywords

acute lymphoblastic leukemia
pediatric oncology
quality of life
systematic review
treatment

Access to Document

10.1002/pbc.26489

Cite this

@article{08a911b1b6a947229c3881b9937e3cfe,

title = "Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review",

abstract = "Children with acute lymphoblastic leukemia (ALL) undergo intense anticancer treatment. We systematically reviewed 22 studies evaluating 2,073 ALL patients{\textquoteright} health-related quality of life (HRQL) and its clinical/demographic correlates during treatment. Overall HRQL was significantly reduced on treatment. Despite HRQL improvements over time, longitudinal studies reported a proportion of children continued to experience reduced HRQL after treatment completion. We found inconsistent associations between clinical/demographic factors and HRQL outcomes. Tentative evidence emerged for worse HRQL being associated with intensive phases of chemotherapy, corticosteroid therapy, experiencing greater toxicity, older age, and female sex. Longitudinal studies are needed to identify children at-risk of reduced HRQL.",

keywords = "acute lymphoblastic leukemia, pediatric oncology, quality of life, systematic review, treatment",

author = "Fardell, {Joanna E.} and Janine Vetsch and T. Trahair and Mateos, {M. K.} and Grootenhuis, {M. A.} and Touyz, {L. M.} and Marshall, {G. M.} and Wakefield, {C. E.}",

note = "Publisher Copyright: {\textcopyright} 2017 Wiley Periodicals, Inc.",

year = "2017",

month = sep,

doi = "10.1002/pbc.26489",

language = "English",

volume = "64",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - Health-related quality of life of children on treatment for acute lymphoblastic leukemia

T2 - A systematic review

AU - Fardell, Joanna E.

AU - Vetsch, Janine

AU - Trahair, T.

AU - Mateos, M. K.

AU - Grootenhuis, M. A.

AU - Touyz, L. M.

AU - Marshall, G. M.

AU - Wakefield, C. E.

PY - 2017/9

Y1 - 2017/9

N2 - Children with acute lymphoblastic leukemia (ALL) undergo intense anticancer treatment. We systematically reviewed 22 studies evaluating 2,073 ALL patients’ health-related quality of life (HRQL) and its clinical/demographic correlates during treatment. Overall HRQL was significantly reduced on treatment. Despite HRQL improvements over time, longitudinal studies reported a proportion of children continued to experience reduced HRQL after treatment completion. We found inconsistent associations between clinical/demographic factors and HRQL outcomes. Tentative evidence emerged for worse HRQL being associated with intensive phases of chemotherapy, corticosteroid therapy, experiencing greater toxicity, older age, and female sex. Longitudinal studies are needed to identify children at-risk of reduced HRQL.

AB - Children with acute lymphoblastic leukemia (ALL) undergo intense anticancer treatment. We systematically reviewed 22 studies evaluating 2,073 ALL patients’ health-related quality of life (HRQL) and its clinical/demographic correlates during treatment. Overall HRQL was significantly reduced on treatment. Despite HRQL improvements over time, longitudinal studies reported a proportion of children continued to experience reduced HRQL after treatment completion. We found inconsistent associations between clinical/demographic factors and HRQL outcomes. Tentative evidence emerged for worse HRQL being associated with intensive phases of chemotherapy, corticosteroid therapy, experiencing greater toxicity, older age, and female sex. Longitudinal studies are needed to identify children at-risk of reduced HRQL.

KW - acute lymphoblastic leukemia

KW - pediatric oncology

KW - quality of life

KW - systematic review

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85014568018&partnerID=8YFLogxK

U2 - 10.1002/pbc.26489

DO - 10.1002/pbc.26489

M3 - Review article

C2 - 28266135

AN - SCOPUS:85014568018

SN - 1545-5009

VL - 64

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 9

M1 - e26489

ER -

Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review

Abstract

Keywords

Access to Document

Fingerprint

Cite this